Tiantian Yu

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Gas Chromatography Mass Spectrometry

Capillary Electrophoresis

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Yongjie Deng, Yao Yao, Yanni Wang, Tiantian Yu, Wenhao Cai, Dingli Zhou, Feng Yin, Wan-Li Liu, Yuying Liu, Chuanbo Xie, Jian Guan, Yumin Hu, Peng Huang, Weizhong Li
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)
Yongjie Deng, Yao Yao, Yanni Wang, Tiantian Yu, Wenhao Cai, Dingli Zhou, Feng Yin, Wan-Li Liu, Yuying Liu, Chuanbo Xie, Jian Guan, Yumin Hu, Peng Huang, Weizhong Li
An end-to-end deep learning method for mass spectrometry data analysis to reveal disease-specific metabolic profiles. Nature communications 15 (1) (2024)
Jiang-Jiang Li, Tiantian Yu, Peiting Zeng, Jingyu Tian, Pan-Pan Liu, Shuang Qiao, Shijun Wen, Yumin Hu, Qiao Liu, Wenhua Lu, Hui Zhang, Peng Huang
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer. Nature communications 15 (1) (2024)